Media highlight UC's FLASH radiotherapy trial
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
November 17, 2022
The Cincinnati Enquirer featured the story of Dr. Alan Jobe, a Cincinnati Children's researcher who has beaten the odds of a glioblastoma diagnosis with the help of his team of University of Cincinnati physicians.
May 6, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, was featured in a VJOncology video discussing a recent Phase III glioma trial.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
May 24, 2022
The University of Cincinnati's College of Medicine and College-Conservatory of Music collaborate on the innovative Dementia and the Arts course and intervention for community members with cognitive disorders and their family members.
May 19, 2022
Local 12 highlighted the University of Cincinnati's Christopher T. Richards and the UC Health mobile stroke unit, which has been dispatched more than 1,100 times since launching in August 2020.
May 10, 2022
The University of Cincinnati's Mladen golubic and Sian Cotton were featured on WVXU's Cincinnati Edition to discuss non-pharmacological approaches to pain management and an upcoming symposium.
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
May 23, 2022
The University of Cincinnati's Dr. Jennifer O’Toole is co-editor of the book “Women in Pediatrics: The Past, Present and Future.”
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.